Violet Research Institute
See how your profile stacks up against this role.
We compared the job requirements to your profile to show where you're strong and where you fall short.
Violet Research Institute (VRI) is building the future of personalized medicine for patients with genetic diseases. We're at the frontier of a new era in medicine — one where treatments can be designed for individual patients based on their unique biology. Recent breakthroughs in science, engineering, and regulatory pathways have made this possible, but much of this work remains nascent and distributed across disparate efforts globally. We're unifying, refining, and scaling these efforts into a cohesive platform. For each patient we serve, we deeply understand their biology, then design and manufacture a targeted treatment that can be delivered in months instead of years.
We combine the urgency and execution mindset of a startup with the mission-driven openness of a nonprofit, allowing us to collaborate broadly and move quickly on behalf of the patients we serve. We've brought together leading researchers, engineers, and organizations across omics, therapeutic design, manufacturing, clinical care, and AI to move from insight to action as quickly as possible.
VRI is founded by the family of our first patient, Violet, and is led by Michael Buckley, Siranush Babakhanova and Steve Turner. Our team is deeply cross-disciplinary and first-principles driven. We value builders, experts, and generalists who are excited to work across domains, challenge conventional approaches, and increase access to personalized medicine.
We are hiring a hands-on Research Associate to Senior Research Associate to support molecular biology and assay development for an active therapeutic program. The primary work centers on nucleic acid purification and quantitative PCR (qPCR and digital droplet PCR) used to measure the knockdown efficiency of antisense oligonucleotides (ASOs) against a disease-relevant target. The role also supports cell culture and stem cell differentiation work as needed.
This is an excellent set of hands with a strong track record for clean, reproducible bench work. It is a demanding, fast-paced environment with shifting priorities and frequent new asks, and it offers meaningful contribution to patient-directed science and broad exposure to a growing organization.
After you apply, unlock the direct contact details of the people who actually make the call. A quick follow-up makes you 5x more likely to land an interview.
Marcus Rivera
Chief Revenue Officer
AbbVie
Capstan Therapeutics
YLabs
American Institutes for Research
Vanguard Clinical, Inc.
